Application of mir-146a-5p in the treatment of visceral hypersensitivity in irritable bowel syndrome
1. The technology of mir-146a-5pagomir and irritable bowel syndrome, which is applied in the medical field, can solve the problems of intestinal permeability, serotonin signaling pathway and abnormal visceral or body hypersensitivity, so as to reduce the risk of irritable bowel syndrome. Effects of Visceral Hypersensitivity in Shock Syndrome
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment approach
[0028] Visceral hypersensitivity refers to the enhanced sensitivity and responsiveness of visceral tissues to various mechanical and chemical stimuli, including visceral hyperalgesia and allodynia, and the volume and pressure threshold of the colorectum are significantly reduced when dilated stimuli are stimulated. At present, the mechanism of visceral hypersensitivity in IBS has not been fully clarified, which may include increased sensitivity of visceral receptors, abnormal sensory afferent nerves, and increased excitability of central visceral sensory neurons. In addition, endocrine and various neurotransmitter abnormalities, intestinal microorganisms and Low-grade inflammation is also involved in the formation of visceral hypersensitivity in IBS.
[0029] Agomir is a specially labeled and chemically modified double-stranded small RNA that regulates the biological functions of target genes by simulating endogenous miRNA.
[0030] In order to make the above and other objects...
Embodiment 1
[0031] Example 1 Detection of serum mir-146a-5p expression in patients with irritable bowel syndrome
[0032]The included research subjects included 5 patients with irritable bowel syndrome (irritable bowel syndrome), all of whom were visiting the Department of Gastroenterology at Qilu Hospital of Shandong University (visceral hypersensitivity state), and a total of 5 healthy volunteers were included in the healthy control group. The diagnostic criteria of diarrhea-predominant irritable bowel syndrome refer to the Rome III diagnostic criteria. Exclusion criteria were: patients with other diseases that caused diarrhea (tumor, thyroid disease, celiac disease, etc.); patients with a history of abdominal surgery or alarm symptoms (anemia, gastrointestinal bleeding, obvious weight loss, abdominal mass); patients with blood coagulation Abnormal function or severe organic disease affecting heart, liver and kidney function; pregnant or breastfeeding. Take 3ml of venous blood from 10 ...
Embodiment 2
[0034] Example 2 Establishment of mouse irritable bowel syndrome disease model and agomir intervention
[0035] The mice were fasted for 24 hours, and the mice were anesthetized by intraperitoneal injection of 1% pentobarbital (0.2ml / only), and the anal tube was inserted into the anus of the mice at one time, and TNBS (80mg / kg) was injected once at about 5cm from the anus as an enema After forming a model, the blank control group was given an enema with equal volume of normal saline. After the enema, the mice were turned upside down for about 30 minutes to prevent the liquid from flowing out. The Agomir intervention method is to start hsa-mir-146a-5p agomir (3nmol / bird) enema seven days after TNBS modeling, and enema once every three days. The disease model control group and the blank control group are given an equal volume of normal saline enema. On the 28th day, the colon dilatation test was performed to evaluate visceral hypersensitivity, and then the mice were sacrificed t...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com